Herpesviruses are ubiquitous and continue to be responsible for significant morbidity and mortality in the human population. In addition, with the increasing incidence of syndromes in which immunosuppression represents a base, there is a corresponding increase in numbers of clinically significant herpesvirus infections. The long-term objective of this proposal is a neurovirulence, and neuroinvasiveness--knowledge that is fundamental to design of methods for control of these agents. Although the primary interest is in Herpes simplex type I (HSV-I), studies presented. With respect to HSV-I, a molecular and functional analysis of the latent phase transcription units facilitate viral reactivation, and a definition of other viral genes functioning in reactivation is also sought. Comparative studies will be concerned with HSV-II and PrV. Investigations of CMV (initially murine, and then human) will focus on identifying latently. Infected cells and defining viral transcription in these cells.
These aims will be accomplished in experimental animals (principally mice and rabbits), and will involve the application of contemporary molecular biological approaches coupled with more traditional virologic and experimental pathologic methods. In studies of HSV neuroinvasiveness and latency, animals will be inoculated on rear footpads, and lumbosacral spinal ganglia will be the organs of particular interest. Viral reactivation studies will employ the rabbit cornea-epinephrine model. Cytomegalovirus will be studied principally in murine spleens after parenteral inoculation. When a foundation has been established in the model, investigations of appropriate human autopsy-derived material will follow. Of particular importance with respect to methods will be those concerned with 1) the generation and application of HSV-1 recombinants with various inserts and deletions in the genomic region encoding the latency associated transcription unit, 2) biological analysis of viral genes involved in neuroinvasiveness and neurovirulence, and 3) technologies for development of a more readily investigated """"""""reactivation system"""""""" than the rabbit cornea model presently serving as the base for study. In all systems, continued application of in situ hybridization technologies to identify involved cells and viral transcripts will be employed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI006246-27
Application #
3124281
Study Section
Experimental Virology Study Section (EVR)
Project Start
1978-11-01
Project End
1995-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
27
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
O'Neil, J E; Loutsch, J M; Aguilar, J S et al. (2004) Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model. J Virol 78:5038-44
Marquart, M E; Zheng, X; Tran, R K et al. (2001) A cAMP response element within the latency-associated transcript promoter of HSV-1 facilitates induced ocular reactivation in a mouse hyperthermia model. Virology 284:62-9
Bloom, D C; Stevens, J G (1994) Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J Virol 68:3761-72
Farrell, M J; Margolis, T P; Gomes, W A et al. (1994) Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo. J Virol 68:5337-43
Yuhasz, S A; Dissette, V B; Cook, M L et al. (1994) Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology 202:272-80
Huang, C J; Rice, M K; Devi-Rao, G B et al. (1994) The activity of the pseudorabies virus latency-associated transcript promoter is dependent on its genomic location in herpes simplex virus recombinants as well as on the type of cell infected. J Virol 68:1972-6
Guzowski, J F; Wagner, E K (1993) Mutational analysis of the herpes simplex virus type 1 strict late UL38 promoter/leader reveals two regions critical in transcriptional regulation. J Virol 67:5098-108
Sedarati, F; Margolis, T P; Stevens, J G (1993) Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology 192:687-91
Yuhasz, S A; Stevens, J G (1993) Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness. J Virol 67:5948-54
Huang, C J; Goodart, S A; Rice, M K et al. (1993) Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter. J Virol 67:5109-16

Showing the most recent 10 out of 35 publications